MBX Biosciences Posts $1.29 GAAP Loss Per Share in Q3

John Kim

1 min read

Add as a preferred source on Google

MBX Biosciences Posts $1.29 GAAP Loss Per Share in Q3

The company expects its $481.6 million in cash and investments to support operations into 2029.

By John Kim

Published Nov 10, 2026, 7:12 PM EST

MBX Biosciences posted a GAAP loss of $1.29 per share for the third quarter. The company expects its $481.6 million in cash and investments to support operations into 2029.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.